9 active not recruiting. 9 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Active not recruiting 9 |
| Phase 2 | 6 | Active not recruiting 6 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD INCA034176 - Chronic Graft-versus-host-disease | Phase 1 / Phase 2 | Active not recruiting | Incyte Corporation | 32 | 2025-06-25 | 2026-08-10 |
| TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) TDI01 suspension - GVHD, Chronic | Phase 1 / Phase 2 | Active not recruiting | Beijing Tide Pharmaceutical Co., Ltd | 60 | 2024-02-06 | 2025-09-26 |
| Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage HUFF-01 - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Active not recruiting | Hokkaido University Hospital | 8 | 2023-12-01 | 2026-10-15 |
| Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers DERMASEAL, Plasma Film, Standard of Care - Foot Ulcer, Diabetic | Phase 1 | Active not recruiting | Vitruvian Medical Devices, Inc. | 26 | 2022-10-03 | 2024-12-27 |
| A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease TQ05105 Tablet - Chronic Graft Versus Host Disease | Phase 1 / Phase 2 | Active not recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 45 | 2021-06-25 | 2025-12-03 |
| Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease Leflunomide - Chronic Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease | Phase 1 | Active not recruiting | City of Hope Medical Center | 18 | 2020-09-14 | 2026-10-19 |
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Active not recruiting | Sashwati Roy | 100 | 2019-01-08 | 2025-09-26 |
| Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation MPH966 - Chronic Graft vs Host Disease, Chronic Graft-Versus-Host Disease | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 16 | 2016-04-28 | 2026-11-03 |
| Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease Treg-enriched infusion, Interleukin-2 - Chronic Graft Versus Host Disease, Chronic GVHD | Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 25 | 2013-11-01 | 2026-02-05 |
Bronchiolitis Obliterans Syndrome (9) · Diabetic Foot (2) · Burns (1) · Cerebral Hemorrhage (1) · Diabetes Mellitus (1) · Pressure Ulcer (1) · Wounds and Injuries (1)
Bronchial Diseases (9) · Bronchiolitis (9) · Bronchiolitis Obliterans (9) · Graft vs Host Disease (9) · Immune System Diseases (9) · Lung Diseases (9) · Lung Diseases, Obstructive (9) · Organizing Pneumonia (9) · Respiratory Tract Diseases (9) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Diabetes Complications (2) · Diabetic Angiopathies (2) · Diabetic Neuropathies (2)
Interleukin-2 (1) · Leflunomide (1) · Petroleum (1) · Standard of Care (1) · axatilimab (1)
Beijing Tide Pharmaceutical Co., Ltd (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · City of Hope Medical Center (1) · Dana-Farber Cancer Institute (1) · Hokkaido University Hospital (1) · Incyte Corporation (1) · National Cancer Institute (NCI) (1) · Sashwati Roy (1) · Vitruvian Medical Devices, Inc. (1)
United States (5) · China (3) · Japan (1)
Amandeep Salhotra (1) · John Koreth, MBBS, DPhil (1) · Najla El Jurdi, M.D. (1) · Sashwati Roy, PhD (1)
PMID 34398099, PMID 35475885, PMID 40009501
R01CA183559 (1)